Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNano Genomics Inc (BNGO) vs State Street PDR S&P Retail ETF (XRT) Price & Performance

BioNano Genomics IncTrade
State Street PDR S&P Retail ETFTrade

Price performance (Past 24H)

Key statistics

BioNano Genomics Inc vs State Street PDR S&P Retail ETF — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while State Street PDR S&P Retail ETF trades at $88.96. The key difference: State Street PDR S&P Retail ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.

BNGOXRT
Market Cap
$13.66M
Sector
HealthBroad Market / Factor
52-Week High
$4.92$92.35
52-Week Low
$1.06$77.28
Enterprise Value
$16.26M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNano Genomics Inc

BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.

The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.

State Street PDR S&P Retail ETF

XRT (SPDR S&P Retail ETF) trades at $88.83, down 1.94% on the day, with technical indicators showing a bullish overall signal despite recent weakness. The ETF maintains neutral oscillators but strong directional movement indicators. Recent retail sales data shows five consecutive months of consumer spending growth, though sentiment remains challenged by inflation pressures and energy costs. The ETF provides diversified exposure to the retail sector with upcoming dividend distribution scheduled for June 2026.

The retail sector faces mixed signals with sustained consumer spending but macroeconomic headwinds. XRT's technical setup suggests potential near-term support around $88-89 levels, while fundamental exposure to discretionary retail remains sensitive to consumer confidence and inflation trends. Key risks include deteriorating consumer sentiment and competitive pressures within the retail landscape.

Returns comparison

Trailing returns across standard periods

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Read more on BNGO

About State Street PDR S&P Retail ETF

XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.

Read more on XRT